RecruitingNot applicableNCT06581315

Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma

Studying Leukoencephalopathy with calcifications and cysts

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Principal Investigator
Changzhen Shang, MD
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Intervention
Donafenib(drug)
Enrollment
204 target
Eligibility
18-75 years · All sexes
Timeline
20242032

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06581315 on ClinicalTrials.gov

Other trials for Leukoencephalopathy with calcifications and cysts

Additional recruiting or active studies for the same condition.

See all trials for Leukoencephalopathy with calcifications and cysts

← Back to all trials